How Much Does Vyleesi Cost vs Compounded PT-141?

Brand Vyleesi (bremelanotide, the drug also called PT-141) costs about $930 to $956 cash for a box of four autoinjectors. The manufacturer's savings program cuts that to $0 for most women with commercial insurance, or $99 a box (about $25 a dose) without coverage. Compounded PT-141 from telehealth providers costs about $99 to $231 a month depending on the form and plan length. The brand savings price only applies to women who fit Vyleesi's narrow label.

So the $930 sticker price is not what most women who qualify pay. Whether you qualify, and how much support you want, matters more than which number is smaller.

How do Vyleesi and compounded PT-141 prices compare?

Prices can change, so confirm the current price before you pay.

The Vyleesi savings program has fine print. You must be 18 or older. Government insurance, such as Medicaid or TRICARE, doesn't qualify. Copay help covers 2 fills every 30 days, and each prescription is 4 autoinjectors.

Which is cheaper per dose, Vyleesi or compounded PT-141?

If you qualify, Vyleesi through the savings program is the cheapest option here. That is partly because of how PT-141 is used. You take it as needed, not every day. The Vyleesi label says to inject at least 45 minutes before sex, take no more than one dose in 24 hours, and not use more than 8 doses a month.

Here is the math. With commercial coverage through the savings program, Vyleesi can cost nothing. Without coverage, a month of 4 doses costs $99, and the 8-dose maximum costs $198 (two $99 boxes). The cheapest compounded plan in the table, Riovie's nasal spray, is also $99 a month. Every other compounded plan listed costs more.

The comparison stops there because compounded plans charge by the month. The provider pages we checked don't list how many doses a month includes. Before you compare any compounded plan to a $24.75 Vyleesi dose, ask how many doses you get.

The compounded price also buys more than the medicine. Riovie's plans, for example, include licensed clinician review, dose changes when clinically appropriate, portal messaging and check-ins, supplies, shipping to your door and ongoing monitoring. A Vyleesi box is four autoinjectors. Getting the prescription, the diagnosis and any follow-up is separate.

Who can get Vyleesi at the savings price?

The savings price only helps if you can get a Vyleesi prescription, and the label is narrow. Vyleesi is approved only for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). In plain terms, that means low desire that is new for you, happens with any partner or in any situation, and causes you real distress or trouble in your relationship.

The label also rules out low desire caused by another medical or mental health condition, by problems in the relationship, or by a medication. It is not approved for women after menopause. Insurance coverage varies and often needs prior authorization for that exact diagnosis.

Real life rarely fits that box. One r/TwoXChromosomes post was titled "There is a direct link between the chores and my libido." In another thread, a woman said her doctor asked why she cared about her libido, and one of the top replies read: "if you were a man, this would be a crisis." Low desire tangled up with exhaustion, a partner or a prescription is exactly the kind the label excludes.

That is where compounded PT-141 comes in. It is made by state-licensed US compounding pharmacies and prescribed by licensed clinicians. It is not FDA approved, and it is not the same as, or interchangeable with, Vyleesi. Our clinical team can prescribe PT-141 if it fits your goal and your health history.

What do you get for the money with PT-141?

The money buys a real shot at wanting sex again. In two 24-week trials of 1,267 premenopausal women with HSDD (average age 39), 58% of women on the brand 1.75 mg injection counted as responders, compared with 35% on placebo. Gains in desire showed up by week 4, the first check, and lasted to the end of the trials.

The number of satisfying sexual encounters did not differ significantly between the drug and placebo. PT-141 was studied for desire and the distress of losing it, so that is the result to expect.

These results come from the FDA-approved Vyleesi injection. Compounded versions have not been evaluated by FDA for safety, effectiveness or quality.

Nausea is the side effect to plan around. About 40% of women in the trials got it, usually about 30 minutes after the injection, lasting a median of about 2.4 hours. For most women it gets better with the second dose. In the trials, 13% needed anti-nausea medicine and 8% stopped early because of it. Taking a dose and then feeling queasy for a couple of hours is not ideal before sex, which is one reason a clinician who can adjust your dose is worth having.

PT-141 raises blood pressure and lowers heart rate for a while after each dose, usually returning to normal within 12 hours. It is not for women with uncontrolled high blood pressure or known heart disease.

About 1% of women taking up to 8 doses a month developed darker patches on the face, gums or breasts, and the patches didn't always fade after stopping. The risk is higher with darker skin and with daily dosing.

Tell your clinical team if you take oral naltrexone for alcohol or opioid use, because the label says to avoid using the two together. Use effective birth control while taking PT-141, and stop if you think you might be pregnant. Per the label, tell your provider if your symptoms haven't improved after 8 weeks.

If you want your desire back and you want someone managing your dose and your nausea, take the quiz. Our clinical team will see whether PT-141 fits your goal and your health history, and build a plan around getting your desire back.